戻る Agenda
Session 7: Decentralized, Virtual and Remote Trials
Session Chair(s)
Scott Askin, MSc
Global Program Regulatory Director
Novartis Pharma AG, Switzerland
Francesca Cerreta, PharmD, MPharm, MS
Principal Scientific Officer
European Medicines Agency, Netherlands
Session 6: Decentralized, virtual and remote trials
Speaker(s)
Introduction: Current Regulation and Guidance
Scott Askin, MSc
Novartis Pharma AG, Switzerland
Global Program Regulatory Director
TeleMedicine: Setting the Standards in Remote Trials?
Andy Fischer
Medgate, Switzerland
President, ISfTeH & CEO
FDA’s Perspective on Innovative Clinical Trial Designs using Digital Tools
M. Khair ElZarrad, PhD, MPH
FDA, United States
Director, Office of Medical Policy, CDER
Decentralized, virtual and remote trials – How is the EU enabling success
Francesca Cerreta, PharmD, MPharm, MS
European Medicines Agency, Netherlands
Principal Scientific Officer